Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 21 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomesMcMillan, M.; Porritt, K.; Kralik, D.; Costi, L.; Marshall, H.
2021Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort studyWurzel, D.; McMinn, A.; Hoq, M.; Blyth, C.C.; Burgner, D.; Tosif, S.; Buttery, J.; Carr, J.; Clark, J.E.; Cheng, A.C.; Dinsmore, N.; Francis, J.R.; Kynaston, A.; Lucas, R.; Marshall, H.; McMullan, B.; Singh-Grewal, D.; Wood, N.; Macartney, K.; Britton, P.N.; et al.
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2013Parental and societal support for adolescent immunization through school based immunization programsMarshall, H.; Collins, J.; Sullivan, T.; Tooher, R.; O'Keefe, M.; Skinner, S.; Watson, M.; Burgess, T.; Ashmeade, H.; Braunack-Mayer, A.
2004Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young childrenBelshe, R.; Newman, F.; Anderson, E.; Wright, P.; Karron, R.; Tollefson, S.; Henderson, F.; Meissner, H.; Madhi, S.; Roberton, D.; Marshall, H.; Loh, R.; Sly, P.; Murphy, B.; Tatem, J.; Randolph, V.; Hackell, J.; Gruber, W.; Tsai, T.
2012Rotavirus vaccination for prevention of serious acute gastroenteritis and the importance of postlicensure safety monitoringClarke, M.; Marshall, H.
2010Acellular pertussis vaccine at birth and one month induces antibody responses by two months of ageWood, N.; McIntyre, P.; Marshall, H.; Roberton, D.
2004Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months oldBelshe, R.; Newman, F.; Tsai, T.; Karron, R.; Reisinger, K.; Roberton, D.; Marshall, H.; Schwartz, R.; King, J.; Henderson, F.; Rodriguez, W.; Severs, J.; Wright, P.; Keyserling, H.; Weinberg, G.; Bromberg, K.; Loh, R.; Sly, P.; McIntyre, P.; Ziegler, J.; et al.
2013Parental perspectives of vaccine safety and experience of adverse events following immunisationParrella, A.; Gold, M.; Marshall, H.; Braunack-Mayer, A.; Baghurst, P.
2005Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old childrenRoberton, D.; Marshall, H.; Nolan, T.; Sokal, E.; Diez-Domingo, J.; Flodmark, C.; Rombo, L.; Lewald, G.; de la Flor, J.; Casanaovas, J.; Verdaguer, J.; Mares, J.; Van Esso, D.; Dieussaert, I.; Stoffel, M.